STOP2030
@stop2030.org
An international partnership to implement a new two-in-one medicine for helminthiasis
Today we’re presenting our fixed-dose co-formulation of ivermectin and albendazole (FDC) at the Innovation Fair 2025 in Brussels — an event that brings together innovation ecosystems from Europe, Africa, and the Mediterranean.
October 23, 2025 at 10:10 AM
Today we’re presenting our fixed-dose co-formulation of ivermectin and albendazole (FDC) at the Innovation Fair 2025 in Brussels — an event that brings together innovation ecosystems from Europe, Africa, and the Mediterranean.
The REALISE study, our clinical trial to evaluate the safety in large populations of our fixed-dose coformulation of ivermectin and albendazole (FDC), has reached an important milestone.
October 1, 2025 at 2:43 PM
The REALISE study, our clinical trial to evaluate the safety in large populations of our fixed-dose coformulation of ivermectin and albendazole (FDC), has reached an important milestone.